The Masterclass will feature a series of presentations and discussions focusing on:

Recent updates and developments in antithrombotic treatment strategies, including the evolving role of NOACs in NVAF and VTE
management.

Knowledge exchange
and experience sharing on
managing complex clinical
situations and high-risk
patients, including those
with cardiovascular
comorbidities, frailty,
cancer-associated VTE.

Perspectives and
approaches in patient management from real-life settings, such as the use
of digital tools in optimising patient care.

Abbreviations: AF, atrial fibrillation; NOAC, non-vitamin K antagonist oral anticoagulant; NVAF, non-valvular atrial fibrillation; VTE, venous thromboembolism.